Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytek Biosciences Inc CTKB

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion... see more

Recent & Breaking News (NDAQ:CTKB)

Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference

GlobeNewswire November 21, 2022

Cytek® Biosciences Introduces Cytek Cloud

GlobeNewswire November 15, 2022

Cytek Biosciences Reports Third Quarter 2022 Financial Results

GlobeNewswire November 9, 2022

Cytek® Biosciences Names Chris Williams Chief Operating Officer

GlobeNewswire October 31, 2022

Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022

GlobeNewswire October 26, 2022

Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference

GlobeNewswire October 26, 2022

Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference

GlobeNewswire August 30, 2022

Cytek Biosciences Reports Second Quarter 2022 Financial Results

GlobeNewswire August 10, 2022

Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference

GlobeNewswire July 21, 2022

Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022

GlobeNewswire July 20, 2022

Cytek Biosciences to Host Inaugural Analyst and Investor Day

GlobeNewswire June 1, 2022

Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit

GlobeNewswire May 24, 2022

Cytek Biosciences Reports First Quarter 2022 Financial Results

GlobeNewswire May 11, 2022

Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022

GlobeNewswire April 28, 2022

Cytek Biosciences Appoints Todd Garland Chief Commercial Officer

GlobeNewswire April 28, 2022

Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire February 23, 2022

Cytek to Participate in the 42nd Annual Cowen Health Care Conference

GlobeNewswire February 16, 2022

Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

GlobeNewswire February 11, 2022

Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity

GlobeNewswire January 5, 2022

Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis System

GlobeNewswire November 17, 2021